Dr. Jennifer L. Gruenenfelder, MD

Dr. Gruenenfelder practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Gruenenfelder's NPI, 1922063627, was assigned on April 18, 2006. Dr. Gruenenfelder graduated from Columbia University College of Physicians and Surgeons in 1995. Dr. Gruenenfelder holds Idaho license M-15918.

Dr. Gruenenfelder's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Gruenenfelder's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. Dr. Gruenenfelder is also affiliated with St. Luke's Boise Medical Center. The medical group on file is OB/GYN University Associates. Dmand AI also links Dr. Gruenenfelder to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gruenenfelder practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Gruenenfelder's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Gruenenfelder is licensed in Idaho.

CMS data shows 663 Medicare services from Dr. Gruenenfelder across 10 procedure codes in 2024, for 243 Medicare patients. Medicare paid $37,653 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 243 Medicare patients who saw Dr. Gruenenfelder in 2024. The largest group is 65 to 74, with 115 patients. 70% of them have high cholesterol, and 65% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gruenenfelder's median patient age at 73, with 86% women.

In 2024, Dr. Gruenenfelder wrote 1,562 Medicare Part D claims for 404 patients. 83% of them were for generic drugs. CMS names the drug for 1,409 of them, across 27 drugs with 11 or more claims each, at $193,832 in total drug cost. In 2023, CMS named 1,148 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Gruenenfelder for performance year 2024, reported as part of a group. Dr. Gruenenfelder accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Gruenenfelder, published from 2015 to 2023. The most frequent topics are Botulinum Toxins, Type A, Injections, Intramuscular and Sacrum. Dr. Gruenenfelder's most frequent co-authors are Kevin D. Benson, MD, Craig Vance Comiter, MD and Michael J. Kennelly, MD.

CMS Open Payments shows 434 general payments to Dr. Gruenenfelder from 19 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 58% of the total. Allergan Inc. paid the most, $75,740.

Dr. Gruenenfelder graduated from Columbia University College of Physicians and Surgeons in 1995.